본문 바로가기
KERD
논문KCI 등재

Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Lymphocyte subpopulations producing cytokines and exerting regulatory functions represent key immune elements. Given their reciprocal interdependency lymphocyte subpopulations are usually assayed as diagnostic panels, rather than single biomarkers for specialist clinical use. This retrospective analysis on lymphocyte subpopulations, analyzed over the last few years in an outpatient laboratory in Northeast Italy, contributes to the establishment of reference values for several regulatory lymphocytes currently lacking such reference ranges for the general population. Mean values and ranges in a sample of Caucasian patients (mean age 42±8,5 years), were provided for Th1, Th2, Th17, Th-reg, Tc-reg, Tc-CD57+ and B1 lymphocytes. The results are consistent with what is found in literature for the single subtypes and are: Th1 157.8±60.3/ml (7.3%±2.9); Th2 118.2±52.2/ml (5.4%±2.5); Th17 221.6±90.2/ml (10.5%±4.4); Th-reg 15.1±10.2/ml (0.7%±0.4); Tc-reg 5.8±4.7/ml (0.3%±0.2); Tc-CD57+ 103.7±114.1/ml (4.6%±4.7); B1 33.7±22.8/ml (1.5%±0.9); (Values are mean±SD). The results show that despite their variability, mean values are rather consistent in all age or sex groups and can be used as laboratory internal reference for this regulatory panel. Adding regulatory cells to lymphocyte subpopulations panels allows a more complete view of the state of the subject’s immune network balance, thus improving the personalization and the “actionability” of diagnostic data in a systems medicine perspective.

Abstract

Lymphocyte subpopulations producing cytokines and exerting regulatory functions represent key immune elements. Given their reciprocal interdependency lymphocyte subpopulations are usually assayed as diagnostic panels, rather than single biomarkers for specialist clinical use. This retrospective analysis on lymphocyte subpopulations, analyzed over the last few years in an outpatient laboratory in Northeast Italy, contributes to the establishment of reference values for several regulatory lymphocytes currently lacking such reference ranges for the general population. Mean values and ranges in a sample of Caucasian patients (mean age 42±8,5 years), were provided for Th1, Th2, Th17, Th-reg, Tc-reg, Tc-CD57+ and B1 lymphocytes. The results are consistent with what is found in literature for the single subtypes and are: Th1 157.8±60.3/ml (7.3%±2.9); Th2 118.2±52.2/ml (5.4%±2.5); Th17 221.6±90.2/ml (10.5%±4.4); Th-reg 15.1±10.2/ml (0.7%±0.4); Tc-reg 5.8±4.7/ml (0.3%±0.2); Tc-CD57+ 103.7±114.1/ml (4.6%±4.7); B1 33.7±22.8/ml (1.5%±0.9); (Values are mean±SD). The results show that despite their variability, mean values are rather consistent in all age or sex groups and can be used as laboratory internal reference for this regulatory panel. Adding regulatory cells to lymphocyte subpopulations panels allows a more complete view of the state of the subject’s immune network balance, thus improving the personalization and the “actionability” of diagnostic data in a systems medicine perspective.

참고문헌 (113)

  1. Tosato, F, "Biological variability of lymphocyte subsets of human adults", blood. Clin. Chim. Acta, 424, pp.159~163 (2013)
  2. 최종범, "Reference Values for Peripheral Blood Lymphocyte Subsets in a Healthy Korean Population", Immune Network, 14(6), pp.289~295 (2014), 대한면역학회
  3. McCoy, J. P. Jr, "Current practices in clinical flow cytometry. A practice survey by the American Society of Clinical Pathologists", Am. J. Clin. Pathol, 111, pp.161~168 (1999)
  4. Yanaba, K, "B-lymphocyte contributions to human autoimmune disease", Immunol. Rev, 223, pp.284~299 (2008)
  5. Doreau, A, "Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus", Nat. Immunol, 10, pp.778~785 (2009)
  6. Victorino, R. M, "Alteration in T lymphocyte subpopulations in inflammatory bowel disease", Clin. Exp. Immunol, 41, pp.156~165 (1980)
  7. Blanco, P, "Cytotoxic T lymphocytes and autoimmunity", Curr. Opin. Rheumatol, 17, pp.731~734 (2005)
  8. Niwa, F, "Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease", Geriatr. Gerontol. Int, 12, pp.102~107 (2012)
  9. Kieseier, B. C, "Immune circuitry in the peripheral nervous system", Curr. Opin. Neurol, 19, pp.437~445 (2006)
  10. Stinissen, P, "Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies", Crit Rev. Immunol, 17, pp.33~75 (1997)
  11. Prat, A, "Migration of multiple sclerosis lymphocytes through brain endothelium", Arch. Neurol, 59, pp.391~397 (2002)
  12. Luckheeram, R. V, "CD4(+)T cells: differentiation and functions", Clin. Dev. Immunol, 2012, pp.925135~ (2012)
  13. Libby, P, "Inflammation and immunity in diseases of the arterial tree: players and layers", Circ. Res, 116, pp.307~311 (2015)
  14. Kim, J. D, "Role of Th1 and Th17 cells in the development and complexity of coronary artery disease:comparison analysis by the methods of flow cytometry and SYNTAX score", Coron. Artery Dis, 26, pp.604~611 (2015)
  15. Robertson, M. J, "Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression", Clin. Exp. Immunol, 141, pp.326~332 (2005)
  16. Fehervari, Z, "Lymphocytes in Alzheimer’s disease", Nat. Immunol, 17, pp.355~ (2016)
  17. Asano, M, "Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation", J. Exp. Med, 184, pp.387~396 (1996)
  18. McNally, A, "CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2homeostasis", Proc. Natl. Acad. Sci. U. S. A, 108, pp.7529~7534 (2011)
  19. Van, P. L, "Homeostasis and selftolerance in the immune system: turning lymphocytes off", Science, 280, pp.243~248 (1998)
  20. Stumhofer, J. S, "Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system", Nat. Immunol, 7, pp.937~945 (2006)
  21. Hood, L, "Systems approaches to biology and disease enable translational systems medicine", Genomics Proteomics Bioinformatics, 10, pp.181~185 (2012)
  22. Lemberger, T, "Systems biology in human health and disease", Mol. Syst. Biol, 3, pp.136~ (2007)
  23. Lindquist, J. A, "Systems biology of T cell activation", Ernst Schering Found. Symp. Proc, pp.43~61 (2007)
  24. Hood, L, "Integrating big data and actionable health coaching to optimize wellness", BMC Med, 13, pp.4~ (2015)
  25. Kutukculer, N, "CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-gamma) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency", Int. J. Immunopathol. Pharmacol, 29, pp.241~251 (2016)
  26. Yamamoto, J, "Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells", J. Leukoc. Biol, 68, pp.568~574 (2000)
  27. Maggi, L, "CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC", Eur. J. Immunol, 40, pp.2174~2181 (2010)
  28. Gonzalez, Y, "CD161 expression defines a Th1", Th17 polyfunctional subset of resident memory T lymphocytes in bronchoalveolar cells, 2015, pp.10, e0123591~
  29. Hannet, I, "Developmental and maturational changes in human blood lymphocyte subpopulations", Immunol. Today, 13, pp.215~218 (1992)
  30. Shearer, W. T, "Lymphocyte subsets in healthy children from birth through 18years of age: the pediatric AIDS clinical trials group P1009study", J. Allergy Clin. Immunol, 112, pp.973~980 (2003)
  31. Nebe, T, "Multi-centric determination of reference ranges for automated blood counts", Laboratoriums Medizin, 35 (2011)
  32. Herklotz, R, "Metaanalysis of reference values in hematology", Ther. Umsch, 63, pp.5~24 (2006)
  33. Rout, N, "Enhanced Th1", Th17 functions of CD161+CD8+ T cells in mucosal tissues of rhesus macaques, 2016, pp.11, e0157407~
  34. Ohkura, N, "FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents", Trends Pharmacol. Sci, 32, pp.158~166 (2011)
  35. Rudensky, A. Y, "Regulatory T cells and Foxp3", Immunol. Rev, 241, pp.260~268 (2011)
  36. Beres, A. J, "CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity", J. Immunol, 189, pp.464~474 (2012)
  37. Santagostino, A, "An Italian national multicenter study for the definition of reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults", Haematologica, 84, pp.499~504 (1999)
  38. Maini, M. K, "Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men", Genitourin. Med, 72, pp.27~31 (1996)
  39. Buchwald, J, "sources and studies in the history of mathematics and physical sciences", pp.17~30 (2011), springer
  40. Kim, S, "Nonparametric functional central limit theorem for time series regression with application to self-normalized confidence interval", J. Multivar. Anal, 133, pp.277~290 (2015)
  41. Shevach, E. M, "CD4+ CD25+ suppressor T cells: more questions than answers", Nat. Rev. Immunol, 2, pp.389~400 (2002)
  42. Churlaud, G, "Human and mouse CD8(+)CD25(+)FOXP3(+) regulatory T cells at steady state and during interleukin-2 therapy", Front. Immunol, 6, pp.171~ (2015)
  43. Kared, H, "CD57 in human natural killer cells and T-lymphocytes", Cancer Immunol. Immunother, 65, pp.441~452 (2016)
  44. Focosi, D, "CD57+ T lymphocytes and functional immune deficiency", J. Leukoc. Biol, 87, pp.107~116 (2010)
  45. Perez-Andres, M, "The nature of circulating CD27+CD43+ B cells", J. Exp. Med, 208, pp.2565~2566 (2011)
  46. Griffin, D. O, "Human B1 cells are CD3-: A reply to 'A human equivalent of mouse B-1 cells?' and 'The nature of circulating CD27+CD43+ B cells'", J. Exp. Med, 208, pp.2566~2569 (2011)
  47. Talaat, R. M, "Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)", Clin. Exp. Immunol, 176, pp.291~300 (2014)
  48. Wood, K. L, "Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation", Front. Biosci, 14, pp.3771~3781 (2009)
  49. Saunders, J. A, "CD4+ regulatory and effector", memory T cell subsets profile motor dysfunction in Parkinson's disease, 2012, pp.7, 927~938
  50. Salonen, R, "Lymphocyte subsets in the cerebrospinal fluid in active multiple sclerosis", Ann. Neurol, 25, pp.500~502 (1989)
  51. Vojdani, A, "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I. Evid. Based Complement", Alternat. Med, 2011, pp.927294~ (2011)
  52. Belardelli, F, "Role of interferons and other cytokines in the regulation of the immune response", APMIS, 103, pp.161~179 (1995)
  53. Sugita, S, "Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet's disease", Arthritis Res.Ther, 14, pp.R99~ (2012)
  54. Fletcher, J. M, "T cells in multiple sclerosis and experimental autoimmune encephalomyelitis", Clin. Exp. Immunol, 162, pp.1~11 (2010)
  55. Korn, T, "IL-17 and Th17 Cells", Annu. Rev. Immunol, 27, pp.485~517 (2009)
  56. Eisenstein, E. M, "The T(reg)", Th17cell balance: a new paradigm for autoimmunity, 2009, pp.65, 26R~31R
  57. Kuo, M. L, "Evaluation of Th1", Th2 ratio and cytokine production profile during acute exacerbation and convalescence in asthmatic children, 2001, pp.86, 272~276
  58. Nanba, T, "Increases of the Th1", Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease, 2009, pp.19, 495~501
  59. Falivene, J, "Th17 and Th17", Treg ratio at early HIV infection associate with protective HIV-specific CD8(+)T-cell responses and disease progression, 2015, pp.5, 11511~
  60. Yu, Z. X, "The ratio of Th17", Treg cells as a risk indicator in early acute respiratory distress syndrome, 2015, pp.19, 82~
  61. Ji, L, "The ratio of Treg", Th17cells correlates with the disease activity of primary immune thrombocytopenia, 2012, pp.7, e50909~
  62. Cunnusamy, K, "Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells", Clin. Immunol, 152, pp.115~126 (2014)
  63. Baughman, E. J, "Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis", J. Autoimmun, 36, pp.115~124 (2011)
  64. Baumgarth, N, "The double life of a B-1 cell: selfreactivity selects for protective effector functions", Nat. Rev. Immunol, 11, pp.34~46 (2011)
  65. Villoslada, P, "Data integration and systems biology approaches for biomarker discovery:challenges and opportunities for multiple sclerosis", J. Neuroimmunol, 248, pp.58~65 (2012)
  66. Buriani, A, "Toxicology of herbal products" (2017), Springer
  67. Buriani, A, "Toxicology of herbal products" (2017), Springer
  68. Buriani, A, "The systems biology oriented. Holistic vision of personalized medicine and the emerging concept of proactive herbal medicine", J. J. Intern. Medicine, 1, pp.007~ (2015)
  69. Oriss, T. B, "Crossregulation between T helper cell (Th)1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1", J. Immunol, 158, pp.3666~3672 (1997)
  70. Damsker, J. M, "Th1and Th17 cells: adversaries and collaborators", Ann. N. Y. Acad. Sci, 1183, pp.211~221 (2010)
  71. Song, K, "TH1 cytokine response of CD57+ T-cell subsets in healthy controls and patients with alcoholic liver disease", Alcohol, 24, pp.155~167 (2001)
  72. Ekkens, M, "Th1 and Th2 cells help CD8T-cell responses", Infect. Immun, 75, pp.2291~2296 (2007)
  73. Geering, B, "Living and dying for inflammation: neutrophils, eosinophils, basophils", Trends Immunol, 34, pp.398~409 (2013)
  74. de Visser, K. E, "Paradoxical roles of the immune system during cancer development", Nat. Rev. Cancer, 6, pp.24~37 (2006)
  75. Brombacher, F, "Novel IL-12 family members shed light on the orchestration of Th1responses", Trends Immunol, 24, pp.207~212 (2003)
  76. Chong, W. P, "NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-gamma-IL-27 axis", J. Exp. Med, 212, pp.1739~1752 (2015)
  77. Garlanda, C, "The interleukin-1 family: back to the future", Immunity, 39, pp.1003~1018 (2013)
  78. Korn, T, "Th17cells: effector T cells with inflammatory properties", Semin. Immunol, 19, pp.362~371 (2007)
  79. Romagnani, S, "The Th1", Th2 paradigm, 1997, pp.18, 263~266
  80. Janeway, J. C. A, "Immunobiology, 5th Edition, The immune system in health and disease", pp.333~337 (2001), Garland science
  81. Basu, R, "The Th17family: flexibility follows function", Immunol. Rev, 252, pp.89~103 (2013)
  82. de, B. J, "Difficult asthma in children: an analysis of airway inflammation", J. Allergy Clin. Immunol, 113, pp.94~100 (2004)
  83. Meyer-Hoffert, U, "Th2- and to a lesser extent Th1-type cytokines upregulate the production of both CXC (IL-8 and gro-alpha) and CC (RANTES, eotaxin, eotaxin-2, MCP-3 and MCP-4)chemokines in human airway epithelial cells", Int. Arch. Allergy Immunol, 131, pp.264~271 (2003)
  84. Min, B, "Basophils induce Th2 immunity: is this final answer?", Virulence, 1, pp.399~401 (2010)
  85. Knoops, L, "IL-9-induced expansion of B-1b cells restores numbers but not function of B-1 lymphocytes in xid mice", J. Immunol, 172, pp.6101~6106 (2004)
  86. Zhu, J, "T helper 2 (Th2) cell differentiation, type 2innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production", Cytokine, 75, pp.14~24 (2015)
  87. Wang, C, "IL-25 promotes Th2 Immunity responses in asthmatic mice via nuocytes activation", PLoS One, 11, pp.e0162393~ (2016)
  88. Su, J, "IL-25 downregulates Th1", Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease, 2013, pp.19, 720~728
  89. Tian, Y, "IL-21 and T Cell Differentiation: Consider the Context", Trends Immunol, 37, pp.557~568 (2016)
  90. Leonard, W. J, "IL-21 Signaling in Immunity. F1000Res. 5", ~ (2016)
  91. Tosolini, M, "Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer", Cancer Res, 71, pp.1263~1271 (2011)
  92. Saito, S, "Th1", Th2, Am. J. Reprod. Immunol, pp.2010, 63[DOI]
  93. van den Berg, W. B, "Th17cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics", Semin. Arthritis Rheum, 43, pp.158~170 (2013)
  94. Busman-Sahay, K. O, "Cytokine crowdsourcing: multicellular production of TH17-associated cytokines", J. Leukoc. Biol, 97, pp.499~510 (2015)
  95. Gharibi, T, "Biological effects of IL-21 on different immune cells and its role in autoimmune diseases", Immunobiology, 221, pp.357~367 (2016)
  96. Ju, B, "Interleukin-21administration leads to enhanced antigen-specific T cell responses and natural killer cells in HIV-1 vaccinated mice", Cell. Immunol, 303, pp.55~65 (2016)
  97. Cope, A, "The Th1 life cycle: molecular control of IFN-gamma to IL-10switching", Trends Immunol, 32, pp.278~286 (2011)
  98. Pedroza-Pacheco, I, "Interaction between natural killer cells and regulatory T cells:perspectives for immunotherapy", Cell. Mol. Immunol, 10, pp.222~229 (2013)
  99. Taams, L. S, "Modulation of monocyte", macrophage function by human CD4+CD25+ regulatory T cells, 2005, pp.66, 222~230
  100. Lewkowicz, N, "Neutrophil--CD4+CD25+ T regulatory cell interactions:a possible new mechanism of infectious tolerance", Immunobiology, 218, pp.455~464 (2013)
  101. McNally, A, "CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2homeostasis", Proc. Natl. Acad. Sci. U. S. A, 108, pp.7529~7534 (2011)
  102. Rother, N, "Disturbed T cell signaling and altered Th17 and Regulatory T cell subsets in the pathogenesis of systemic lupus erythematosus", Front. Immunol, 6, pp.610~ (2015)
  103. Diehl, S, "The two faces of IL-6 on Th1", Th2 differentiation, 2002, pp.39, 531~536
  104. Newcomb, D. C, "Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production", J. Allergy Clin. Immunol, 127, pp.1006~1013 (2011)
  105. Kimura, A, "IL-6: regulator of Treg", Th17 balance, 2010, pp.40, 1830~1835
  106. Patera, A. C, "Interleukin 17 modulates the immune response to vaccinia virus infection", Virology, 299, pp.56~63 (2002)
  107. Zhong, X, "Reciprocal generation of Th1", Th17 and T(reg) cells by B1 and B2 B cells, 2007, pp.37, 2400~2404
  108. Wang, Y, "Induction of Th17 cell differentiation by B-1 cells", Front. Immunol, 3, pp.281~ (2012)
  109. Kotake, S, "Elevated ratio of Th17 cell-derived Th1 cells (CD161(+)Th1 cells) to CD161(+)Th17 cells in peripheral blood of early-onset rheumatoid arthritis patients", Biomed. Res. Int, 2016, pp.4186027~ (2016)
  110. Li, J, "Natural killer cells regulate Th1", Treg and Th17, J. Cell Mol. Med, pp.2016, 20[DOI]
  111. Hsing, C. H, "Expression of IL-19correlates with Th2 cytokines in uraemic patients", Nephrol. Dial. Transplant, 22, pp.2230~2238 (2007)
  112. Liao, S. C, "IL-19 induced Th2 cytokines and was up-regulated in asthma patients.", J. Immunol, 173, pp.6712~6718 (2004)
  113. Allen, J. E, "IL-17and neutrophils: unexpected players in the type 2 immune response", Curr. Opin. Immunol, 34, pp.99~106 (2015)

관련 논문AI추천

이 간행물의 다른 논문 (7건)